Reaction
Pancreatic Neuroendocrine Tumour Metastatic reporting signals
As of the last recalculation, Pancreatic Neuroendocrine Tumour Metastatic appears in 236 FAERS reports alongside 7 co-occurring drug terms. The strongest observed disproportionality signal is OCTREOTIDE ACETATE (PRR 361.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Octreotide Acetate | 82 | 361.3 | 362.2 |
| Everolimus | 96 | 279.8 | 280.3 |
| Temozolomide | 24 | 111.7 | 111.8 |
| Everolimus Tablets | 13 | 72.3 | 72.4 |
| Capecitabine | 51 | 62.4 | 62.5 |
| Sunitinib Malate | 21 | 51.6 | 51.6 |
| Exenatide | 14 | 24.9 | 24.9 |